ClinicalTrials.Veeva

Menu

Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive

U

Universidad Autonoma de Madrid

Status

Completed

Conditions

Covid19

Treatments

Diagnostic Test: Roth´s Test

Study type

Observational

Funder types

Other

Identifiers

NCT04832828
PI-4321

Details and patient eligibility

About

The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.

Enrollment

114 patients

Sex

All

Ages

12 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. having been diagnosed as COVID-19 positive and with symptoms compatible with Sars-Cov-2 infection in the last 7 days prior to assessment,
  2. having an understanding of Spanish,
  3. and having no history of respiratory pathology prior to the current infection.

Trial design

114 participants in 1 patient group

COVID+ Group
Description:
Patients diagnosed with Covid19 positive in last 7 days
Treatment:
Diagnostic Test: Roth´s Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems